RadNet at Raymond James Conference: Embracing AI for Growth
RadNet Inc. (NASDAQ:RDNT) presented its strategic vision at the 47th Annual Raymond James Institutional Investor Conference, emphasizing its expansion in digital health and AI. The company projects significant revenue growth for 2026, with imaging centers expected to grow by 16-18% and digital health by 50%. CFO Mark Stolper outlined plans for AI integration and new center openings to drive future growth, while also acknowledging challenges like rising labor costs and weather impacts.
RadNet Inc Stock: Leading Outpatient Imaging Provider Faces Short-Term Headwinds Amid Strong Long-Term Sector Tailwinds
RadNet Inc, a major U.S. outpatient diagnostic imaging provider, is navigating short-term market sentiment while benefiting from strong long-term growth trends driven by an aging population. The company specializes in various imaging services, operating over 380 facilities, and differentiating itself through proprietary technology and AI integration. Despite potential reimbursement pressures and labor costs, institutional investors like Allspring Global Investments show confidence in RadNet’s fundamentals and its strategic focus on organic expansion and efficiency.
Allspring Global Investments Holdings LLC Has $74.38 Million Holdings in RadNet, Inc. $RDNT
Allspring Global Investments Holdings LLC significantly reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 39.9% in the fourth quarter, selling over 694,000 shares but still retaining holdings valued at $74.38 million. Despite this reduction, RadNet generally maintains a "Moderate Buy" consensus rating from analysts with an average price target of $90.43, significantly above its recent share price. The company reported strong Q4 2025 earnings, exceeding analyst expectations for both EPS and revenue, though it continues to show negative net margins and a negative trailing P/E.
Vanguard reorganizes reporting; RDNT ownership shown as 0 (RDNT)
The Vanguard Group has filed an amended Schedule 13G/A, reporting 0 shares beneficially owned in RadNet Inc (RDNT), representing 0% of common stock. This change is due to an internal realignment effective January 12, 2026, where certain Vanguard subsidiaries and business divisions will now report their beneficial ownership separately as per SEC Release No. 34-39538. The filing clarifies that this amendment reflects a reporting change, not a sale or acquisition of RadNet shares, and future filings from Vanguard affiliates may disclose beneficial positions.
Raymond James says helium concerns behind Radnet stock sell-off overblown
Raymond James believes that recent stock sell-offs for RadNet, Inc. (NASDAQ:RDNT) and Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI), driven by concerns over helium supply and pricing, are exaggerated. The firm's analysis, based on discussions with RadNet management, suggests that the issue is primarily price-related rather than a severe supply problem in the U.S. Analysts maintain an optimistic outlook for Lumexa, with significant upside potential.
Raymond James says helium concerns behind Radnet stock sell-off overblown
Raymond James believes that concerns regarding helium supply and pricing, which have contributed to recent sell-offs in RadNet, Inc. (NASDAQ:RDNT) and Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares, are unfounded. The firm suggests the market's reaction is disproportionate to the actual problem, which appears to be price and not supply in the U.S. Analysts remain optimistic about Lumexa, with price targets indicating significant upside potential.
RadNet (RDNT) Acquires Gleamer for €230 Million
RadNet, Inc. (NASDAQ: RDNT) has acquired Paris-based Gleamer SAS for up to €230 million, significantly expanding its radiology AI capabilities. This acquisition positions RadNet's subsidiary, DeepHealth, as the world's largest radiology AI provider, integrating Gleamer's FDA-cleared AI solutions across various imaging modalities. The deal is expected to enhance cost-effectiveness and diagnostic automation, with Gleamer reporting substantial ARR growth and projecting $30 million in ARR by 2026.
RadNet (RDNT) Acquires Gleamer for €230 Million
RadNet, Inc. (NASDAQ: RDNT) has acquired Paris-based Gleamer SAS for up to €230 million, positioning its subsidiary DeepHealth as the world's largest radiology AI provider. The acquisition, structured as an all-cash transaction, integrates Gleamer's FDA-cleared X-ray and musculoskeletal AI into DeepHealth’s portfolio, covering major imaging modalities. RadNet anticipates significant cost effectiveness and diagnostic automation, with DeepHealth subsequently unveiling a comprehensive clinical AI portfolio at ECR 2026.
RadNet (RDNT) CSO trims stake with share sale and donation
RadNet, Inc.'s Chief Strategy Officer, Alma Gregory Sorensen, executed multiple transactions on March 19, 2026, selling 15,000 shares of the company's common stock at prices ranging from $61.38 to $63.59. Additionally, Sorensen made a charitable donation of 7,000 shares. Following these transactions, her direct holdings in RadNet common stock totaled 1,201,923 shares.
RadNet CFO Touts “Unprecedented” Volume Momentum, Sees Digital Health as 2026 Growth Engine
RadNet's CFO Mark Stolper reported "unprecedented" imaging volume momentum exiting 2025, with strong growth in MRI and PET-CT, and guided for substantial revenue and EBITDA growth in 2026 for its imaging centers. The company also projects digital health to be a major growth driver in 2026, with an expected 45-55% growth and a $140 million ARR target, partly fueled by the Gleamer acquisition. RadNet's expansion strategy focuses on tuck-in acquisitions, hospital joint ventures, and new center builds, alongside a strong free cash flow outlook.
Radnet (RDNT) Receives a Buy from Jefferies
Jefferies analyst Brian Tanquilut maintained a Buy rating on Radnet (RDNT) with a price target of $91.00. This follows Radnet's recent quarterly revenue of $547.71 million and a GAAP net loss of $597 thousand, compared to a profit in the previous year. Despite a positive outlook from some analysts, corporate insider sentiment for the stock is negative due to increased selling activity.
How RadNet’s AI Push and Gleamer Deal At RadNet (RDNT) Has Changed Its Investment Story
RadNet's recent participation in healthcare conferences highlighted its strategic pivot towards radiology AI, spearheaded by the acquisition of Gleamer and the global expansion of its DeepHealth platform. This AI-focused initiative is framed as a key short-term catalyst, though it accentuates the underlying tension between significant growth investments and the company's current unprofitability and substantial capital needs. While RadNet projects considerable revenue and earnings growth by 2028, investor perspectives on its fair value vary widely, underscoring the challenge of balancing innovation with financial discipline.
RadNet CSO Sorensen sells $932k in shares
RadNet's Chief Strategy Officer, Alma Gregory Sorensen, sold a total of 20,919 shares of common stock in two separate transactions in March 2026, totaling approximately $1.3 million. Despite these sales, Wall Street maintains a bullish outlook for RadNet, with analysts forecasting profitability for the company this year and price targets suggesting significant upside potential. The company also recently reported strong Q4 2025 earnings, exceeding analyst expectations for both EPS and revenue.
Insider sells 15,000 shares (NASDAQ: RDNT) in Form 144 disclosure
Alma Gregory Sorensen, an insider at RadNet, Inc. (NASDAQ: RDNT), reported recent and proposed transactions via a Form 144 filing. The disclosure details sales of 15,000 shares for over $932,000 and 5,919 shares for over $365,000 on March 18 and March 16, 2026, respectively. The filing also includes entries for restricted stock vesting on earlier dates.
Radnet Insider Sold Shares Worth $932,280, According to a Recent SEC Filing
An insider at RadNet, Inc. (NASDAQ: RDNT) has sold shares valued at $932,280, as reported in a recent SEC filing. The company, a national provider of diagnostic imaging services and related AI solutions, did not disclose further details regarding the insider transaction at this time. This news comes amidst other recent company activities including presentations at healthcare conferences and acquisitions.
Insider Sell: Alma Sorensen Sells 15,000 Shares of RadNet Inc (R
Alma Sorensen, Chief Strategy Officer at RadNet Inc, sold 15,000 shares of the company on March 18, 2026. This transaction brings her total holdings to 1,223,923 shares. RadNet Inc, a provider of outpatient diagnostic imaging services, is currently valued as fairly priced according to its GuruFocus Value, with shares trading at $62.15 against a GF Value of $63.44.
RadNet (NASDAQ:RDNT) Insider Alma Gregory Sorensen Sells 15,000 Shares
RadNet (NASDAQ:RDNT) insider Alma Gregory Sorensen sold 15,000 shares of the company's stock for $932,250, reducing her stake by 1.21%. The sale occurred on March 18, 2026, and was disclosed in an SEC filing. RadNet recently beat earnings estimates, reporting $0.23 EPS and $547.71 million in revenue, and carries a consensus "Moderate Buy" rating from analysts.
RadNet CSO Sorensen sells $932k in shares
RadNet's Chief Strategy Officer, Alma Gregory Sorensen, sold a total of 15,000 shares of the company's common stock for approximately $932,280 on March 18, 2026, and an additional 5,919 shares on March 16, 2026, valued at $365,320. Despite these sales, Sorensen still directly owns over 1.2 million shares. Analysts maintain a bullish outlook on RadNet, with price targets significantly above current trading levels, following strong Q4 2025 earnings which exceeded expectations.
RDNT (NASDAQ: RDNT) Form 144: Broker listed for 5,919 vested shares
RadNet, Inc. (RDNT) has submitted a Form 144 notice for the proposed sale of 5,919 shares of common stock, stemming from restricted stock vesting on three different dates. Morgan Stanley Smith Barney LLC is listed as the broker involved in this procedural disclosure. The filing indicates the intent for a proposed sale, not a completed transaction.
RadNet, Inc. (NASDAQ:RDNT) Q4 2025 earnings call transcript
This document is a transcript of RadNet, Inc.'s Q4 2025 earnings call. It provides a detailed record of the discussions, financial results, and any forward-looking statements made during the call.
Why RadNet (RDNT) Shares Are Sliding Today
RadNet (RDNT) shares fell by 2.8% despite the company outlining strong growth plans and expressing confidence at an investor conference. Management projected significant revenue growth for 2026 in both its imaging centers and digital health business, driven by acquisitions and AI solutions. The stock's volatility is noted, and while the market considers the news meaningful, it hasn't fundamentally altered its perception of the business.
RDNT (NASDAQ: RDNT) insider files to sell 15,000 vested shares
RadNet, Inc. (NASDAQ: RDNT) reported a Rule 144 notice for an insider to sell up to 15,000 shares of common stock, associated with restricted stock vesting. The filing also disclosed a recent sale of 5,919 shares on March 16, 2026, for $365,335.47 by Alma Gregory Sorensen. The filing is considered routine and neutral in sentiment.
RadNet shares gain 3% following $270 million acquisition of AI firm Gleamer
RadNet's shares rose 3% after the company announced its acquisition of Gleamer, an AI firm specializing in radiology solutions, for approximately $270 million. This strategic move aims to integrate Gleamer's AI products into RadNet's expansive radiology network, enhancing diagnostic capabilities and operational efficiency. The acquisition is expected to position RadNet at the forefront of AI-driven healthcare imaging.
Radnet Stock: Here’s Why Numbers Point to 200% Upside Scenario
RadNet (RDNT) recently acquired Gleamer, making its DeepHealth subsidiary the world's largest radiology AI provider, while trading near its 52-week low. The company reported record Q4 revenue and strong growth in its Digital Health segment, with management projecting significant revenue and free cash flow growth for 2026. Analysts maintain buy or outperform ratings, anticipating substantial upside, with TIKR's valuation model suggesting a potential 200% total return by 2030, driven by the scalable AI software business.
Mairs & Power Inc. Acquires 39,752 Shares of RadNet, Inc. $RDNT
Mairs & Power Inc. substantially increased its stake in RadNet, Inc. (NASDAQ:RDNT) by 68.9% in Q3, acquiring 39,752 additional shares and now owning 97,483 shares valued at approximately $7.43 million. This comes as RadNet reported strong Q3 earnings, exceeding analyst expectations with an EPS of $0.23 and revenue of $547.7 million, a 14.8% year-over-year increase. The company holds a "Moderate Buy" consensus rating from analysts with an average price target of $90.43.
RadNet CFO speaks at KeyBanc Capital Markets Healthcare Forum webcast
RadNet, Inc. announced that its Executive Vice President and Chief Financial Officer, Mark Stolper, will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026, at 4:30 p.m. ET. The presentation will be available via live and archived webcasts. This continues RadNet's investor outreach following recent strong financial results and strategic AI advancements.
RadNet, Inc. (NASDAQ:RDNT) Given Average Recommendation of "Moderate Buy" by Analysts
RadNet, Inc. (NASDAQ:RDNT) has received an average "Moderate Buy" rating from analysts, with a consensus 12-month price target of $90.43. Recent analyst coverage includes a reaffirmation of "strong-buy" from Raymond James Financial and target price increases from UBS Group and B. Riley Financial. Institutional investors have also adjusted their positions, with several firms increasing their stakes in the company.
RadNet Inc Stock (ISIN: US75025X1000) Gains Analyst Lift Amid Institutional Shift and $300M Acquisit
RadNet Inc. (ISIN: US75025X1000) is experiencing a strategic momentum, with B. Riley Financial raising its price target to $87, reflecting confidence in the company's aggressive $300 million acquisition strategy for 2026. This optimism is tempered by some institutional investors, such as First Light Asset Management LLC, reducing their stakes, indicating mixed sentiment due to potential execution risks and capital intensity. The company's business model leverages economies of scale in the fragmented diagnostic imaging market, but its substantial acquisition drive will require careful management of cash flow, leverage, and capital structure.
RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum
RadNet, Inc. announced that its Executive Vice President and CFO, Mark Stolper, will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026. The presentation will be available via simultaneous and archived webcasts. RadNet is a national leader in diagnostic imaging services and digital health solutions, operating in multiple states.
Sectra acquiring Oxipit | RadNet's $300M in 2026 acquisitions | Hologic clears hurdle in $18B sale to PE | More
This article summarizes recent merger and acquisition activities in the radiology and medical imaging sector. Key deals include Sectra's acquisition of Oxipit, RadNet's significant investments in 2026 through the acquisition of AI firm Gleamer and several imaging centers, and Hologic's proposed $18B sale to private equity firms TPG and Blackstone. Additionally, Quantum Surgical acquired NeuWave Medical, and RadNet expanded its footprint by acquiring Chesapeake Medical Imaging, Cimar UK, and Northwest Radiology.
JB Capital Partners LP Lowers Stake in RadNet, Inc. $RDNT
JB Capital Partners LP has reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 3.4% in the third quarter, selling 50,000 shares and now holding 1,424,061 shares valued at approximately $108.53 million. Despite this reduction, RadNet remains the largest position in JB Capital Partners LP's portfolio, accounting for 18.4%. Analysts generally maintain a "Moderate Buy" rating for RadNet, with an average price target of $90.43, and the company recently surpassed earnings estimates with $0.23 EPS and revenues increasing by 14.8% year-over-year.
Fred Alger Management LLC Raises Position in RadNet, Inc. $RDNT
Fred Alger Management LLC significantly increased its stake in RadNet, Inc. by 50.7% in Q3, now holding 490,267 shares valued at approximately $37.36 million. This move comes as RadNet reported strong financial results, beating EPS and revenue expectations in its most recent quarter. Wall Street analysts maintain a largely positive outlook on the company, with a consensus "Moderate Buy" rating and a target price of $90.43.
RadNet, Inc. $RDNT Shares Sold by First Light Asset Management LLC
First Light Asset Management LLC reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 38.5% in the third quarter, selling 26,414 shares and retaining 42,280 shares valued at approximately $3.22 million. Despite this reduction, institutional ownership of RadNet remains high at 77.9%, with other major funds increasing their positions. Analysts maintain a "Moderate Buy" rating for RadNet, with an average price target of $90.43, following strong Q3 earnings that surpassed expectations with $0.23 EPS and $547.7 million in revenue.
How Investors Are Reacting To RadNet (RDNT) 2026 AI-Driven Revenue And EBITDA Growth Targets
RadNet recently presented its 2026 financial targets, projecting 17-19% revenue growth and 18-22% EBITDA growth, driven by AI-enabled solutions. This comes despite a 2025 net loss of $18.65 million on $2.04 billion revenue, emphasizing the company's reliance on AI to improve profitability and strengthen its market position. Investors are evaluating whether these AI investments can overcome current losses and capital needs to achieve sustainable profitability and unlock its fair value.
RadNet, Inc. $RDNT Shares Sold by Portolan Capital Management LLC
Portolan Capital Management LLC recently reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 33.6% in the third quarter, selling 114,686 shares while still holding 226,669 shares valued at $17.27 million. RadNet exceeded revenue and EPS expectations in its last quarter, and analysts generally maintain a "Moderate Buy" rating with an average price target of $90.43. Institutional investors collectively own 77.90% of the company's stock.
RadNet’s Gleamer Deal And Short Seller Questions Reshape AI Thesis
RadNet plans to acquire AI medical imaging firm Gleamer for US$270 million, a move that integrates AI tools into its outpatient imaging network. This acquisition, alongside a short-seller report questioning RadNet's accounting, has raised investor debate on the deal's price and strategic fit. Investors are urged to scrutinize RadNet's financial explanations, integration plans, and adherence to transparent reporting practices.
RadNet’s Gleamer Deal And Short Seller Questions Reshape AI Thesis
RadNet (NasdaqGM:RDNT) plans to acquire AI medical imaging firm Gleamer for nearly US$270 million, a move that has sparked investor debate regarding the price and strategic fit. This acquisition, along with a short-seller report questioning RadNet's accounting and performance metrics, places additional scrutiny on the company's financials and disclosure practices. Investors are urged to consider how management explains the purchase price, integration plans, and how AI usage will be reported across RadNet's imaging network.
RadNet Shares Sold by Portolan Capital Management
Portolan Capital Management LLC, an institutional investor, decreased its stake in RadNet, Inc. (NASDAQ:RDNT) by 33.6% in the third quarter of 2025, selling 114,686 shares. This reduction means the firm now owns 0.29% of RadNet, down from 0.44% previously. The move could indicate a shift in investor sentiment regarding the medical imaging company's performance or future prospects, making Portolan's actions noteworthy for market observers.
Alpha Wave Global LP Increases Stake in RadNet, Inc.
Investment firm Alpha Wave Global LP has significantly increased its stake in RadNet, Inc. by 37.6% in the third quarter of 2026, boosting its ownership to 533,279 shares. This move positions Alpha Wave Global as one of RadNet's largest institutional investors, signaling confidence in the medical research company's growth potential and strategic direction. RadNet is a leading provider of outpatient diagnostic imaging services in the U.S.
RadNet Shares Rise on 2026 Revenue and Earnings Growth Projections - News and Statistics
RadNet's stock increased by 2.9% following a presentation outlining strong financial projections for the current year. The diagnostic imaging company anticipates revenue growth between 17% and 19% and an 18% to 22% increase in earnings. Despite a previous decline due to a national employment report, the market reacted positively to the strategic outlook.
RadNet (RDNT) chief strategy officer exercises 62,964 stock options
RadNet, Inc.'s Chief Strategy Officer, Alma Gregory Sorensen, exercised 62,964 employee stock options on March 10, 2026. These options were granted as part of an employment retention plan at DeepHealth, Inc., a RadNet subsidiary, and vested over several years. Following these transactions, Sorensen now directly holds 1,244,842 shares of RadNet common stock.
Ancillary Care Services Market May See a Big Move | Major Giants- RadNet, Amedisys, SYNLAB
The global Ancillary Care Services market, valued at USD 150.5 Billion in 2025, is projected to reach USD 284.7 Billion by 2033, growing at an 8.3% CAGR, driven by increasing chronic diseases and demand for diagnostic services. Key players include Labcorp, Quest Diagnostics, and UnitedHealth Group. The market faces challenges related to cost management and regulatory compliance but presents opportunities in telemedicine and emerging economies.
RadNet at Barclays Conference: Strong Growth and Strategic Focus
RadNet Inc. (NASDAQ:RDNT) presented at the Barclays 28th Annual Global Healthcare Conference, highlighting strong revenue and EBITDA growth in 2025 and projecting continued expansion for 2026, particularly in its digital health segment. The company detailed its strategic focus on outpatient services, technological integration, and acquisitions like Gleamer to manage labor costs and enhance efficiency. CFO Mark Stolper expressed significant excitement about RadNet's current position and future outlook, emphasizing the increasing shift of healthcare services from expensive hospitals to lower-cost outpatient facilities.
RadNet, Inc. $RDNT Shares Sold by Victory Capital Management Inc.
Victory Capital Management Inc. significantly reduced its stake in RadNet, Inc. (NASDAQ:RDNT) during the third quarter, selling 126,631 shares and now owning about 0.19% of the company. Despite this, RadNet reported strong Q3 earnings, beating analyst expectations for both EPS and revenue, with a 14.8% year-over-year revenue increase. The company holds a "Moderate Buy" consensus rating from analysts, with several firms recently raising their price targets.
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
RadNet, Inc. announced that its Executive Vice President and CFO, Mark Stolper, will present at the 28th Annual Barclays Global Healthcare Conference on March 12, 2026, at 8:00 a.m. ET. The presentation will be webcast live and archived online. RadNet is a major national provider of diagnostic imaging services and digital health solutions.
RadNet’s stock price falls 20%, driven down by 3 potential factors
RadNet Inc.'s stock price dropped 20% despite positive earnings and plans to acquire AI firm Gleamer for $270 million. Analysts attribute the decline to the high price paid for Gleamer, concerns raised by a short-seller report about RadNet's same-center growth methodology, and the impact of disclosure questions on investor sentiment given the company's premium valuation. Despite these factors, analysts maintain a positive outlook for RadNet's long-term growth in outpatient imaging.
Neuberger Berman Group LLC Purchases 170,261 Shares of RadNet, Inc. $RDNT
Neuberger Berman Group LLC increased its stake in RadNet, Inc. by 59.4% in the third quarter, acquiring 170,261 additional shares, bringing its total holdings to 456,855 shares valued at $34.8 million. Despite a recent earnings beat, RadNet's stock opened down 9% at $60.69, significantly below the average analyst target price of $90.43, which suggests a "Moderate Buy" consensus. Several other institutional investors also adjusted their positions in RadNet during recent quarters.
RadNet’s Transformational AI Pivot Sets the Stage for 2026: Why a $92 Target Is Next
RadNet (RDNT) is poised for significant growth, with analysts projecting a target price of $92.38, representing a 27.3% potential return. This optimism stems from the company's strong financial performance, outperforming revenue and EBITDA estimates, and its strategic acquisition of AI startup Gleamer. The integration of Gleamer into RadNet’s DeepHealth division is expected to accelerate revenue growth, enhance operational efficiency, and solidify RadNet's position as a global leader in AI-powered health informatics, particularly in addressing radiologist labor shortages and improving clinical outcomes.
RadNet (RDNT) EVP awarded 20,667 common shares in Form 4 filing
RadNet, Inc. Executive Vice President of Financial Planning and Chief Accounting Officer, Mital Patel, was awarded 20,667 common shares on March 3, 2026, as reported in a Form 4 SEC filing. These shares were granted at $0.0000 per share, increasing Patel's direct holdings to 200,175 common shares in the company.
Is 19.3% Fall In RadNet (RDNT) Stock A Buying Opportunity?
The article poses a question regarding whether the 19.3% fall in RadNet (RDNT) stock presents a buying opportunity. The content provided suggests that the article is from Trefis, a financial analysis platform. However, the full content of the analysis itself is not available, as the provided text only displays the website's navigation and terms of use information.
